Agios Pharmaceuticals, Inc. (AGIO) vs Fortrea Holdings Inc. (FTRE)
- Agios Pharmaceuticals, Inc. AGIO 31.59 −0.54%
- Fortrea Holdings Inc. FTRE 20.20 +0.70%
Agios Pharmaceuticals, Inc. and Fortrea Holdings Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Fortrea Holdings Inc. are of similar size ($1.9B and $1.9B). Agios Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 214.4% against −3.38%. Fortrea Holdings Inc. has the higher net margin (−2.58% vs −264.8%) and the higher return on invested capital (0.59% vs −75.0%). Across the 18 metrics below, Fortrea Holdings Inc. leads on 11 and Agios Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | AGIO | FTRE | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.81% | 20.00% | 67.24% |
| Operating margin | (297.72%) | 0.48% | 0.00% |
| Net margin | (264.76%) | (2.58%) | 0.00% |
| Free cash flow margin | (238.54%) | 6.41% | 0.00% |
| Return on equity | (32.95%) | (12.34%) | (50.28%) |
| Return on assets | (30.44%) | (2.51%) | (45.89%) |
| Return on invested capital | (75.02%) | 0.59% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack